2:05 PM
 | 
Jan 09, 2018
 |  BC Innovations  |  Distillery Therapeutics

Cancer

INDICATION: Solid tumors

Mouse studies suggest inhibiting PTPN22 on CD8+ T cells could help treat TGFβ-RII-expressing thymoma. In a mouse model of TGFβ-RII-expressing thymoma, CD8+ T...

Read the full 105 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Innovations

Article Purchase

$18 USD
More Info >